MedPath

Resective Epilepsy Surgery, Quality of life and Economic evaluation.

Recruiting
Conditions
Epilepsy
Registration Number
NL-OMON21022
Lead Sponsor
not apliccable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Included will be patients that are selected for surgery between September 2019 and September 2021 in the Maastricht UMC+ and Amsterdam UMC.

Exclusion Criteria

Excluded will be patients who do not speak Dutch or patients who are considered mentally deficient (TIQ below 70), because they are expected not to be able to fill out the questionnaires. With a disharmonic level of intelligence the verbal IQ (<70) is leading.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome is change in disease specific quality of life (expressed in points change at the QOLIE-31 questionnaire).
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are change in general quality of life (expressed in points change at the EQ-5D questionnaire), seizure frequency (ILAE-classification), use of care (iMCQ), productivity (iPCQ), the correlation between change in quality of life and seizure reduction. Also, based on these outcomes, an economic evaluation will be performed.
© Copyright 2025. All Rights Reserved by MedPath